SPY420.86+5.94 1.43%
DIA338.78+5.82 1.75%
IXIC14,141.48+111.10 0.79%

RAPT Therapeutics Q1 EPS $(0.66) Down From $(0.56) YoY

RAPT Therapeutics (NASDAQ:RAPT) reported quarterly losses of $(0.66) per share. This is a 17.86 percent decrease over losses of $(0.56) per share from the same period last year.

05/11/2021 08:12
RAPT Therapeutics (NASDAQ:RAPT) reported quarterly losses of $(0.66) per share. This is a 17.86 percent decrease over losses of $(0.56) per share from the same period last year.